Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27,264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
REDD-1 aggravates endotoxin-induced inflammation via atypical NF-κB activation.
Lee DK, Kim JH, Kim J, Choi S, Park M, Park W, Kim S, Lee KS, Kim T, Jung J, Choi YK, Ha KS, Won MH, Billiar TR, Kwon YG, Kim YM. Lee DK, et al. Among authors: kim ym, kim t, kim s, kim j, kim jh. FASEB J. 2018 Aug;32(8):4585-4599. doi: 10.1096/fj.201701436R. Epub 2018 Mar 16. FASEB J. 2018. PMID: 29547704
Our data support the likelihood that REDD-1 exacerbates endotoxemic inflammation via atypical NF-kappaB activation by sequestering IkappaBalpha.-Lee, D.-K., Kim, J.-H., Kim, J., Choi, S., Park, M., Park, W., Kim, S., Lee, K.-S., Kim, T., Jung, J …
Our data support the likelihood that REDD-1 exacerbates endotoxemic inflammation via atypical NF-kappaB activation by sequestering IkappaBal …
Arg-Leu-Tyr-Glu Suppresses Retinal Endothelial Permeability and Choroidal Neovascularization by Inhibiting the VEGF Receptor 2 Signaling Pathway.
Park W, Baek YY, Kim J, Jo DH, Choi S, Kim JH, Kim T, Kim S, Park M, Kim JY, Won MH, Ha KS, Kim JH, Kwon YG, Kim YM. Park W, et al. Among authors: kim jy, kim ym, kim t, kim s, kim j, kim jh. Biomol Ther (Seoul). 2019 Sep 1;27(5):474-483. doi: 10.4062/biomolther.2019.041. Biomol Ther (Seoul). 2019. PMID: 31042676 Free PMC article.
N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases.
Yun JA, Kim J, Baek YY, Park W, Park M, Kim S, Kim T, Choi S, Jeoung D, Lee H, Won MH, Kim JY, Ha KS, Kwon YG, Kim YM. Yun JA, et al. Among authors: kim jy, kim ym, kim t, kim s, kim j. Mol Pharmacol. 2019 Dec;96(6):692-701. doi: 10.1124/mol.119.117234. Epub 2019 Oct 8. Mol Pharmacol. 2019. PMID: 31594790
27,264 results
You have reached the last available page of results. Please see the User Guide for more information.